Alimta

Get a Price/Quote

MOQ : 1 Bottle

Alimta Specification

Dosage Form
Lyophilized Powder for Injection

Origin of Medicine
Imported

Salt Composition
Pemetrexed Disodium

Indication
Malignant pleural mesothelioma and non-small cell lung cancer

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Allopathic

Ingredients
Pemetrexed Disodium Hemipenta Hydrate

Physical Form
Injection

Function
Antineoplastic (anti-cancer)

Recommended For
Anti-cancer / Used in the treatment of malignant pleural mesothelioma and non-small cell lung cancer

Dosage
500 mg/vial

Dosage Guidelines
As directed by the oncologist

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store below 25C, protect from light

Administration Route
Intravenous (IV) use after reconstitution

Brand Name
Alimta

Marketed Strength
500 mg

Warning
For single use only; discard unused portion

Prescription
Prescription only medicine

Registration
Registered under pharmaceutical drug regulations

Reconstitution
To be reconstituted with 20 ml 0.9% Sodium Chloride Injection

Alimta Trade Information

Minimum Order Quantity
1 Bottle

Main Domestic Market
All India

About Alimta

Brand Name : Alimta

Content : Pemetrexed For Injection

Strength: Pemetrexed For Injection 500mg

Packing : 500mg

Type : Injection

Manufactured by: Alkem Laboratories Lt............

Powerful Cancer Treatment

Alimta delivers targeted chemotherapy for patients with malignant pleural mesothelioma and non-small cell lung cancer. Its advanced formulation works by interfering with cancer cell growth, helping to manage these aggressive conditions. Regular administration under oncologist guidance ensures optimal efficacy and safety.

Professional Preparation and Administration

Alimta is supplied as a 500 mg vial lyophilized powder and requires precise reconstitution with 20 ml of 0.9% Sodium Chloride Injection. Administration is via intravenous infusion in a clinical setting, ensuring accurate dosing and patient monitoring during treatment sessions.

Stringent Safety and Storage Measures

To maintain effectiveness and safety, Alimta must be stored below 25C and protected from light. As a single-use medication, any unused portion should be safely discarded. Adherence to these guidelines preserves medicine quality and reduces risk of contamination.

FAQs of Alimta:

Q: How is Alimta prepared and administered to patients?

A: Alimta is supplied as a lyophilized powder for injection. Before use, it is reconstituted with 20 ml of 0.9% Sodium Chloride Injection and then administered intravenously by trained healthcare professionals.

Q: What conditions is Alimta prescribed for?

A: Alimta is recommended for adults in the treatment of malignant pleural mesothelioma and non-small cell lung cancer, functioning as a chemotherapeutic agent to slow cancer progression.

Q: When should Alimta be used during cancer treatment?

A: Alimta is used as directed by an oncologist, typically as part of a prescribed chemotherapy regimen for eligible adults diagnosed with the indicated cancers.

Q: Where should Alimta be stored before use?

A: Unopened vials of Alimta must be stored below 25C and protected from light to ensure the medications integrity and effectiveness.

Q: What is the process for using Alimta in clinical practice?

A: After reconstitution, Alimta is administered via intravenous infusion. The remaining unused portion must be discarded as it is a single-use formulation, and all procedures are handled by medical professionals.

Q: What benefits does Alimta offer to patients?

A: Alimta provides antineoplastic action, efficiently targeting cancer cells to help manage mesothelioma and non-small cell lung cancer, improving treatment outcomes under medical supervision.

Q: Is Alimta suitable for self-administration?

A: No, Alimta requires preparation and intravenous administration by trained healthcare personnel in a medical facility. Self-administration is not recommended or permitted.

Tell us about your requirement